Latest period
$2.09B
YoY change
-7.3%
5Y CAGR
+6.8%
Peak year (2024)
$2.07B
Latest annual
$1.92B
Total Equity history chart for Bio-Techne (TECH) from 1989 to 2025
Latest: $1.92B
Total Equity growth chart for Bio-Techne (TECH) from 1989 to 2025
Latest: -7.3%
Total Equity history table for Bio-Techne (TECH) from 1989 to 2025
| 2025 | $1.92B | -7.3% | −$150.04M | ||
| 2024 | $2.07B | +5.2% | +$102.33M | ||
| 2023 | $1.97B | +15.6% | +$264.75M | ||
| 2022 | $1.70B | +8.9% | +$138.80M | ||
| 2021 | $1.56B | +13.2% | +$181.78M | ||
| 2020 | $1.38B | +18.5% | +$215.60M | ||
| 2019 | $1.17B | +8.0% | +$86.44M | ||
| 2018 | $1.08B | +13.5% | +$128.32M | ||
| 2017 | $950.83M | +8.1% | +$71.55M | ||
| 2016 | $879.28M | +3.8% | +$32.34M | ||
| 2015 | $846.93M | +6.5% | +$51.67M | ||
| 2014 | $795.26M | +7.8% | +$57.72M | ||
| 2013 | $737.54M | +9.4% | +$63.10M | ||
| 2012 | $674.44M | +15.1% | +$88.32M | ||
| 2011 | $586.12M | +16.8% | +$84.33M | ||
| 2010 | $501.79M | +9.9% | +$45.31M | ||
| 2009 | $456.48M | -6.3% | −$30.65M | ||
| 2008 | $487.13M | +11.3% | +$49.48M | ||
| 2007 | $437.65M | +28.6% | +$97.30M | ||
| 2006 | $340.35M | +27.1% | +$72.48M | ||
| 2005 | $267.87M | -9.9% | −$29.56M | ||
| 2004 | $297.43M | +25.7% | +$60.81M | ||
| 2003 | $236.62M | +14.6% | +$30.10M | ||
| 2002 | $206.52M | +16.2% | +$28.86M | ||
| 2001 | $177.66M | +25.9% | +$36.51M | ||
| 2000 | $141.15M | +45.8% | +$44.35M | ||
| 1999 | $96.80M | +51.7% | +$33.00M | ||
| 1998 | $63.80M | +32.6% | +$15.70M | ||
| 1997 | $48.10M | +23.7% | +$9.20M | ||
| 1996 | $38.90M | +31.9% | +$9.40M | ||
| 1995 | $29.50M | +28.3% | +$6.50M | ||
| 1994 | $23.00M | +29.2% | +$5.20M | ||
| 1993 | $17.80M | +58.9% | +$6.60M | ||
| 1992 | $11.20M | +77.8% | +$4.90M | ||
| 1991 | $6.30M | +37.0% | +$1.70M | ||
| 1990 | $4.60M | +48.4% | +$1.50M | ||
| 1989 | $3.10M | — | — |
- 2025$1.92B-7.3%
- 2024$2.07B+5.2%
- 2023$1.97B+15.6%
- 2022$1.70B+8.9%
- 2021$1.56B+13.2%
- 2020$1.38B+18.5%
- 2019$1.17B+8.0%
- 2018$1.08B+13.5%
- 2017$950.83M+8.1%
- 2016$879.28M+3.8%
- 2015$846.93M+6.5%
- 2014$795.26M+7.8%
- 2013$737.54M+9.4%
- 2012$674.44M+15.1%
- 2011$586.12M+16.8%
- 2010$501.79M+9.9%
- 2009$456.48M-6.3%
- 2008$487.13M+11.3%
- 2007$437.65M+28.6%
- 2006$340.35M+27.1%
- 2005$267.87M-9.9%
- 2004$297.43M+25.7%
- 2003$236.62M+14.6%
- 2002$206.52M+16.2%
- 2001$177.66M+25.9%
- 2000$141.15M+45.8%
- 1999$96.80M+51.7%
- 1998$63.80M+32.6%
- 1997$48.10M+23.7%
- 1996$38.90M+31.9%
- 1995$29.50M+28.3%
- 1994$23.00M+29.2%
- 1993$17.80M+58.9%
- 1992$11.20M+77.8%
- 1991$6.30M+37.0%
- 1990$4.60M+48.4%
- 1989$3.10M—
Total Equity values are taken from Bio-Techne's reported balance sheets (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Total Equity at Bio-Techne (TECH)
According to Bio-Techne's latest reported financial statements, the company's latest reported total equity is $2.09B. Net assets — also called stockholders' equity — equal total assets minus total liabilities. They represent the residual claim of shareholders on the company's assets and roughly track book value over time.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
In 2025, Bio-Techne (TECH) total equity totalled $1.92B – declined 7.3% year-over-year.
Looking at the 2020–2025 (5 years) stretch, Bio-Techne total equity compounded at +6.8% per year, with mixed annual results across the window.
Bio-Techne total equity peaked at $2.07B in 2024; the latest annual figure is $1.92B in 2025 (7.3% below peak).
Across the available history, total equity reached its high of $2.07B in 2024 and its low of $3.10M in 1989.
Bio-Techne Total Equity by Year
Bio-Techne Total Equity 2025: $1.92B
In 2025, Bio-Techne reported total equity of $1.92B, declined 7.3% below 2024.
Bio-Techne Total Equity 2024: $2.07B
Bio-Techne total equity in 2024 was $2.07B, grew 5.2% from 2023. This figure represents the highest annual value in the available history.
Bio-Techne Total Equity 2023: $1.97B
2023's total equity for Bio-Techne came in at $1.97B, grew 15.6% from 2022.
Bio-Techne Total Equity 2022: $1.70B
Bio-Techne posted total equity of $1.70B in 2022, grew 8.9% from 2021.
Bio-Techne Total Equity 2021: $1.56B
Bio-Techne total equity in 2021 was $1.56B.
See more financial history for Bio-Techne (TECH).
Sector peers by Total Equity
Healthcare peers of Bio-Techne (TECH), ranked by their latest total equity
| $94.11B | |
| $81.54B | |
| $52.61B | |
| $48.67B | |
| $30.52B | |
| $26.54B | |
| $8.66B | |
| −$3.27B |
- $94.11B
- $81.54B
- $52.61B
- $48.67B
- $30.52B
- $26.54B
- $8.66B
- −$3.27B
Frequently asked questions
Bio-Techne (TECH) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation